Therapeutics For Attractive Markets With Unmet Medical Need

AFFiRiS GmbH has been founded in November 2003 and became operative in its state of the art facility in Vienna, Austria in April 2004. The company is conse-quently focused on product deve-lopment of peptide-based vaccines for the treatment of Alzheimer and Atherosclerosis.

AFFiRiS employs highly skilled scientists and technical assistants with expertise in biochemistry, molecular biology, cell biology, immunology and veterinary medicine.

The company is located at the renowned Vienna Biocenter Campus, an international "Center of Excellence" based on both, registered life science companies and university research institutes. As a vital part of this campus AFFiRiS also benefits from the excellent infrastructure at the Biocenter.

For more information about the Campus Vienna Biocenter please refer to: www.viennabiocenter.com